ACADIA Pharmaceuticals
ACAD
#3632
Rank
NZ$4.65 B
Marketcap
$27.91
Share price
-3.01%
Change (1 day)
-8.88%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2023 (TTM): -$1.49

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.59. In 2022 the company made an earnings per share (EPS) of -$2.32 a decrease over its 2021 EPS that were of -$1.82.

EPS history for ACADIA Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.49-35.73%
2022-$2.3227.62%
2021-$1.82-41.67%
2020-$3.1212.5%
2019-$2.77-17.95%
2018-$3.38-17.02%
2017-$4.070.43%
2016-$4.0543.56%
2015-$2.8273.4%
2014-$1.63113.64%
2013-$0.7618.92%
2012-$0.64-15.91%
2011-$0.76-210%
2010$0.69-133.61%
2009-$2.06-30.81%
2008-$2.987.5%
2007-$2.77-0.62%
2006-$2.794.55%
2005-$2.67-14.61%
2004-$3.12-84.26%
2003-$19.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$0.47-129.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.22-302.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.40-690.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.38-1,631.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.87-531.52%๐Ÿ‡บ๐Ÿ‡ธ USA